Latent tuberculosis infection (LTBI) screening is a vital public health measure aimed at reducing the spread of tuberculosis (TB). LTBI screening can detect individuals who are infected with TB but do not have any symptoms and are therefore not aware that they are infectious. This allows for early treatment of latent TB infection, which can prevent the development of active TB disease.
There are several methods of latent tuberculosis screening available, including the tuberculin skin test (TST) and interferon-gamma release assays (IGRAs). The most appropriate method of latent TB screening will depend on individual circumstances, such as the risk of exposure to TB, previous history of latent TB infection, and whether or not the individual has been vaccinated against TB.
Latent tuberculosis screening is an important measure to take in order to prevent the spread of tuberculosis. It can be done through a test called latent tuberculin skin test or interferon-gamma release assays. The most appropriate method will depend on individual circumstances and what the person’s risk factors are for exposure to TB, previous history of latent TB infection, and whether or not the individual has been vaccinated against TB. latent tuberculosis screening can help detect those individuals who are infected but do not have any symptoms and are therefore not aware that they are infectious; this way, early treatment can be given and active TB disease can be prevented from developing.
Latent tuberculosis screening is recommended for people who have been in close contact with someone with active TB, as well as those who have a higher risk for exposure to TB. latent tuberculosis screening can also be done on people who have recently arrived from a country where TB is more common. latent tuberculosis screening is a simple and quick test that can make a big difference in preventing the spread of TB. latent tuberculosis screening is an important measure to take in order to prevent the spread of tuberculosis. It can be done through a test called latent tuberculin skin test or interferon-gamma release assays. The most appropriate method will depend on individual circumstances and what the person’s risk factors are for exposure to TB, previous history of latent TB infection, and whether or not the individual has been vaccinated against TB. Latent tuberculosis screening can help detect those individuals who are infected but do not have any symptoms and are therefore not aware that they are infectious; this way, early treatment can be given and active TB disease can be prevented from developing.
